Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Document Type
Year range
1.
Rev Lat Am Enfermagem ; 31: e3761, 2023 Mar 27.
Article in Spanish, English, Portuguese | MEDLINE | ID: covidwho-2260705

ABSTRACT

OBJECTIVE: to investigate the prevalence of skin lesions and factors associated with the use of N95 respirators among health professionals in Brazil. METHOD: cross-sectional study conducted with 11,368 health professionals using a respondent-driven sampling method adapted for online environments. Univariate and multivariate analyses were performed to investigate the association between the "skin lesions with the use of N95 respirators" variable and gender, professional category, workplace, training, COVID-19 diagnosis, and availability of sufficient and high-quality Personal Protective Equipment. RESULTS: the prevalence of skin lesions was 61.8%. Women were 1.203 times (95% CI: 1.154-1.255) more likely to develop a lesion than men. The chances of skin lesions in psychologists (PR=0.805; 95% CI: 0.678-0.956) and dentists (PR=0.884; 95% CI: 0.788-0.992), were lower when compared to Nursing professionals. Professionals with a positive COVID-19 diagnosis and working in the Intensive Care Unit have an increased chance of presenting skin lesions (PR=1.074; 95% CI: 1.042-1.107); (PR=1.203; 95% CI: 1.168-1.241), respectively. CONCLUSION: the prevalence of skin lesions caused by the use of N95 respirators was 61.8% and was associated with female gender, professional category, workplace, training, COVID-19 diagnosis, and availability of sufficient and highquality Personal Protective Equipment. (1) The overall prevalence of skin lesions was 61.8%. (2) The most affected professional category was Nursing. (3) Women were more likely to develop skin lesions than men.


Subject(s)
COVID-19 , Respiratory Protective Devices , Skin Diseases , Male , Humans , Female , COVID-19/epidemiology , COVID-19/prevention & control , N95 Respirators , Brazil , Cross-Sectional Studies , COVID-19 Testing , Skin Diseases/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL